OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade
He Meng, Zifan Chen, Li Zhang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e007054-e007054
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data
Zifan Chen, Yang Chen, Yu Sun, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13

Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors
Xinyue Han, Yingcui Chen, Hong Xie, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Inflammatory marker cut-off points and prognosis in incurable cancer: validation study
Gabriella da Costa Cunha, Geisiane Alves da Silva, Larissa Calixto‐Lima, et al.
BMJ Supportive & Palliative Care (2025), pp. spcare-005302
Closed Access

Development and validation of a preoperative CT-based risk scoring system for predicting recurrence-free survival in patients undergoing curative surgery for gastric cancer
Zhengqi Zhu, Haipeng Gong, Jianan Gu, et al.
European Journal of Radiology (2024) Vol. 171, pp. 111303-111303
Closed Access | Times Cited: 2

Development and validation of a prognostic immunoinflammatory index for patients with gastric cancer
Zhi-Chang Ba, Xi-Qing Zhu, Zhiguo Li, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 24, pp. 3059-3075
Open Access | Times Cited: 2

Association between systemic immune inflammation index and osteoarthritis in US adults: a cross-sectional study
Jianguo Fang, Cai Liu, Duojun Wang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1

Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma
Eric Robles Garibay, Sylvia M. Cruz, Sean J. Judge, et al.
Journal of Surgical Oncology (2024) Vol. 130, Iss. 3, pp. 543-551
Closed Access | Times Cited: 1

A study predicting long-term survival capacity in postoperative advanced gastric cancer patients based on MAOA and subcutaneous muscle fat characteristics
Yubo Han, Yaoyuan Chang, Jiaqi Wang, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Explanation of the obesity paradox of immunotherapy in cancer patients using CT-derived adipose composition parameters: A systematic review and meta-analysis
Jie Lou, Yusheng Guo, Lingli Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113699-113699
Closed Access | Times Cited: 1

The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy
Yanzhao Zhou, Jingzhong Ouyang, Hongcai Yang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1193-1206
Open Access

Prognostic Impact of Myosteatosis on Survival with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Taha Koray Şahin, Deniz Can Güven
Clinical Nutrition ESPEN (2024) Vol. 63, pp. 829-836
Closed Access

Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinoma
Tingting Liu, Xueyuan Chen, Silang Mo, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 9, pp. 2222-2235
Open Access

Severe weight loss during PD-1 treatment is a risk sign of poor prognosis for advanced GC patients
Jun Geng, Ruming Liu, Zhang Lin, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 10, pp. 1483-1490
Closed Access

Page 1 - Next Page

Scroll to top